BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 25630969)

  • 1. Erythropoietin directly stimulates osteoclast precursors and induces bone loss.
    Hiram-Bab S; Liron T; Deshet-Unger N; Mittelman M; Gassmann M; Rauner M; Franke K; Wielockx B; Neumann D; Gabet Y
    FASEB J; 2015 May; 29(5):1890-900. PubMed ID: 25630969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin signaling in osteoblasts is required for normal bone formation and for bone loss during erythropoietin-stimulated erythropoiesis.
    Suresh S; Lee J; Noguchi CT
    FASEB J; 2020 Sep; 34(9):11685-11697. PubMed ID: 32671900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin receptor in B cells plays a role in bone remodeling in mice.
    Deshet-Unger N; Kolomansky A; Ben-Califa N; Hiram-Bab S; Gilboa D; Liron T; Ibrahim M; Awida Z; Gorodov A; Oster HS; Mittelman M; Rauner M; Wielockx B; Gabet Y; Neumann D
    Theranostics; 2020; 10(19):8744-8756. PubMed ID: 32754275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epoxyeicosanoids suppress osteoclastogenesis and prevent ovariectomy-induced bone loss.
    Guan H; Zhao L; Cao H; Chen A; Xiao J
    FASEB J; 2015 Mar; 29(3):1092-101. PubMed ID: 25466887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The TRPV1 ion channel antagonist capsazepine inhibits osteoclast and osteoblast differentiation in vitro and ovariectomy induced bone loss in vivo.
    Idris AI; Landao-Bassonga E; Ralston SH
    Bone; 2010 Apr; 46(4):1089-99. PubMed ID: 20096813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
    Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
    Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin Receptor (EPOR) Signaling in the Osteoclast Lineage Contributes to EPO-Induced Bone Loss in Mice.
    Awida Z; Hiram-Bab S; Bachar A; Saed H; Zyc D; Gorodov A; Ben-Califa N; Omari S; Omar J; Younis L; Iden JA; Graniewitz Visacovsky L; Gluzman I; Liron T; Raphael-Mizrahi B; Kolomansky A; Rauner M; Wielockx B; Gabet Y; Neumann D
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The loss of Cbl-phosphatidylinositol 3-kinase interaction perturbs RANKL-mediated signaling, inhibiting bone resorption and promoting osteoclast survival.
    Adapala NS; Barbe MF; Langdon WY; Nakamura MC; Tsygankov AY; Sanjay A
    J Biol Chem; 2010 Nov; 285(47):36745-58. PubMed ID: 20851882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
    Valverde P; Tu Q; Chen J
    J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin stimulates spleen BMP4-dependent stress erythropoiesis and partially corrects anemia in a mouse model of generalized inflammation.
    Millot S; Andrieu V; Letteron P; Lyoumi S; Hurtado-Nedelec M; Karim Z; Thibaudeau O; Bennada S; Charrier JL; Lasocki S; Beaumont C
    Blood; 2010 Dec; 116(26):6072-81. PubMed ID: 20844235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
    Michael H; Härkönen PL; Väänänen HK; Hentunen TA
    J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased EPO Levels Are Associated With Bone Loss in Mice Lacking PHD2 in EPO-Producing Cells.
    Rauner M; Franke K; Murray M; Singh RP; Hiram-Bab S; Platzbecker U; Gassmann M; Socolovsky M; Neumann D; Gabet Y; Chavakis T; Hofbauer LC; Wielockx B
    J Bone Miner Res; 2016 Oct; 31(10):1877-1887. PubMed ID: 27082941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SHP2 regulates osteoclastogenesis by promoting preosteoclast fusion.
    Zhou Y; Mohan A; Moore DC; Lin L; Zhou FL; Cao J; Wu Q; Qin YX; Reginato AM; Ehrlich MG; Yang W
    FASEB J; 2015 May; 29(5):1635-45. PubMed ID: 25593124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoblast and osteoclast differentiation in an in vitro three-dimensional model of bone.
    Tortelli F; Pujic N; Liu Y; Laroche N; Vico L; Cancedda R
    Tissue Eng Part A; 2009 Sep; 15(9):2373-83. PubMed ID: 19292676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune complex-induced inhibition of osteoclastogenesis is mediated via activating but not inhibitory Fcγ receptors on myeloid precursor cells.
    Grevers LC; de Vries TJ; Everts V; Verbeek JS; van den Berg WB; van Lent PL
    Ann Rheum Dis; 2013 Feb; 72(2):278-85. PubMed ID: 22918932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lectin-like oxidized low-density lipoprotein receptor-1 abrogation causes resistance to inflammatory bone destruction in mice, despite promoting osteoclastogenesis in the steady state.
    Nakayachi M; Ito J; Hayashida C; Ohyama Y; Kakino A; Okayasu M; Sato T; Ogasawara T; Kaneda T; Suda N; Sawamura T; Hakeda Y
    Bone; 2015 Jun; 75():170-82. PubMed ID: 25744064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polycythemia is associated with bone loss and reduced osteoblast activity in mice.
    Oikonomidou PR; Casu C; Yang Z; Crielaard B; Shim JH; Rivella S; Vogiatzi MG
    Osteoporos Int; 2016 Apr; 27(4):1559-1568. PubMed ID: 26650379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent inhibitory effect of Foeniculum vulgare Miller extract on osteoclast differentiation and ovariectomy-induced bone loss.
    Kim TH; Kim HJ; Lee SH; Kim SY
    Int J Mol Med; 2012 Jun; 29(6):1053-9. PubMed ID: 22447109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alisol-B, a novel phyto-steroid, suppresses the RANKL-induced osteoclast formation and prevents bone loss in mice.
    Lee JW; Kobayashi Y; Nakamichi Y; Udagawa N; Takahashi N; Im NK; Seo HJ; Jeon WB; Yonezawa T; Cha BY; Woo JT
    Biochem Pharmacol; 2010 Aug; 80(3):352-61. PubMed ID: 20412788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.